79517-31-0

Basic information

• Product Name: 23-De(aMinocarbonyl)-23-carboxy VancoMycin
• Synonyms: 23-De(aMinocarbonyl)-23-carboxy VancoMycin;23-De(aMinocarbonyl)-23-carboxy VancoMycin Discontinued;DesaMidovancoMycin B
• CAS NO: 79517-31-0
• Molecular Formula: C66H74Cl2N8O25
• Molecular Weight: 1450.23836
• Product Categories: Aromatics;Chiral Reagents;Drug Analogues;Heterocycles;Intermediates & Fine Chemicals;Metabolites & Impurities;Pharmaceuticals
• Mol File: 79517-31-0.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• Density: 1.66±0.1 g/cm3(Predicted)
• PKA: 2.94±0.70(Predicted)
• CAS DataBase Reference: 23-De(aMinocarbonyl)-23-carboxy VancoMycin(CAS DataBase Reference)
• NIST Chemistry Reference: 23-De(aMinocarbonyl)-23-carboxy VancoMycin(79517-31-0)
• EPA Substance Registry System: 23-De(aMinocarbonyl)-23-carboxy VancoMycin(79517-31-0)

Safety Data

• Hazardous Substances Data: 79517-31-0(Hazardous Substances Data)

Usage

Description

23-De(aMinocarbonyl)-23-carboxy VancoMycin is an analog of the antibiotic Vancomycin, characterized by the replacement of the amine carbonyl group at the 23rd position with a carboxylic acid group. This modification retains the equivalent antibacterial activity of the parent compound, Vancomycin, while potentially offering distinct advantages in terms of stability, solubility, or other pharmaceutical properties.

Uses

Used in Pharmaceutical Industry:
23-De(aMinocarbonyl)-23-carboxy VancoMycin is used as an antibiotic for treating infections caused by gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and other resistant strains. Its equivalent antibacterial activity to Vancomycin makes it a valuable alternative for combating drug-resistant infections.
Additionally, due to its presence as an impurity in commercial preparations of Vancomycin, 23-De(aMinocarbonyl)-23-carboxy VancoMycin may also be utilized in the quality control and assessment of Vancomycin products to ensure their purity and efficacy. This can contribute to the overall safety and effectiveness of antibiotic therapies.